Wellington [New Zealand], November 26 (ANI/Xinhua): The New Zealand Police and all New Zealand Defense Force staff have become the new groups required to be vaccinated in preparation for the transition to the new COVID-19 Protection Framework on December 3.
Hanoi [Vietnam], November 26 (ANI): Another worker in the Vietnamese city Thanh Hoa has died after receiving a Vero Cell COVID-19 vaccine shot, local media reported adding that two others had also passed away due to the vaccination.
Kasauli (Himachal Pradesh) [India], November 26 (ANI): The Central Drugs Laboratory which is set in the mountains of Himachal Pradesh in Kasauli has been at the centre of India's Covid vaccination campaign since its launch early this year. It has cleared almost 1512 million vaccine doses til
Panaji (Goa) [India], November 25 (ANI): Taking a swipe at the Opposition parties for "misleading people" regarding the COVID-19 vaccines during its initial stage, Bharatiya Janata Party national president JP Nadda on Thursday said that they who "bashed the vaccine then and called it name
Patna (Bihar) [India], November 25 (ANI): State Health Minister Mangal Pandey has announced the commencement of a lottery system, for those who inoculated with the second dose of the COVID-19 vaccine in the state, from November 27.
New Delhi [India], November 25 (ANI): The Delhi High Court on Thursday asked the Centre to file an affidavit on the aspects of the administration of booster dose of COVID-19 vaccine necessary or not and the timeline within which the same is proposed to be rolled out.
London [UK], November 25 (ANI): A new study has found a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine.
New Delhi [India], November 25 (ANI): The Union Ministry of Health and Family Welfare (MoHFW) on Thursday said that more than 22.72 crore balance and unutilized Covid-19 vaccine doses are still available with States and Union Territories as of November 25.
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
New Delhi [India], November 25 (ANI): As many as 35 new coronavirus cases were recorded in the last 24 hours in the national capital, according to official data.